More Videos
|
CNBC'S MOST SHARED
- Apartment Vacancy Rate Hits 22-Year High
- Investing in Tech Now
- What You'll See On My NASCAR Documentary Tonight
- Warren Buffett: Economy Needs Another Dose of Viagra
- Warren Buffett Tells CNBC Consumer Sales Remain "Very, Very Soft"
- New Jobless Claims Plunge; Continuing Claims Hit Record
- Citigroup Replaces CFO, Shakes Up Top Management
- Cramer?s Outrage
- The Crack Cocaine of Auction Sites
- Retail Sales Miss the Mark as Consumers Curb Spending
- July 10th in Market History
- Microsoft Plays a Game of Bing Pong
- Options Smell 'Blood' on Infosys
- Christmas in July: Consumers To Out-Scrooge Scrooge
- GM's Second Chance
- Art Cashin: Traders Weigh Obama Policy Changes
- Warren Buffett: Economy Needs Another Dose of Viagra
- Commercial Real Estate: 'Ticking Time Bomb'
- Will LeBron Dunk Tape Ever Be Released?
- Stimulus Critics Put Obama, Democrats on Defensive
- Warren Buffett: Consumer Sales Remain 'Very, Very Soft'
- Busch: Chinese Bank Announces Bombshell
- Lenny Dykstra: 'Bank Fraud' Led to Bankruptcy
- Christmas in July: Consumers to Out-Scrooge Scrooge
- Software Giants Rush to Cash In on Carbon-Trading
- Video Game Makers Finding Gold in Old Titles
- Slideshow: The 15 Highest Grossing Movies of All Time
- Cerberus Won't Let Investors Out of Hedge Fund: Report
RSS FEED
Text Size 
 |
CNBC.com photo composite Gardasil |
] has been testing its cervical cancer vaccine Gardasil on young men (16-23 years old). The company says major data on those clinical trials are expected next year and could help Merck win FDA approval of the shots for males as well as females. The first-of-its-kind product has already sparked a sociopolitical controversy with its recommended use for young women. Imagine the brouhaha if or when Merck starts selling it for young men.That effort is getting a shot in the arm (bad, cliche pun intended) today from doctors at the prestigious M.D. Anderson Cancer Center who write a review in the medical journal "Cancer" about HPV-16 (one of the strains of the human papillomavirus that can lead to cancer) being tied to oropharyngeal, or a type of oral cancer.
The researchers conclude, "To hasten the reduction of HPV-16 in the population, widespread vaccination of adolescent and young adult males should also be considered. Although the cervical cancer...prevention policy of the HPV-16/18 (another leading cancer-causing strain) vaccination of young women and adolescent females are commended, we fear that vaccination programs limited to females will only delay the potential benefit in prevention of HPV-16/18-associated oropgaryngeal cancers, which typically occur in men. We encourage the rapid study of the efficacy and safety of these vaccines in males and, if successful, the recommendation of vaccination in young adult and adolescent males." One of the doctors who wrote the article has been a consultant for GSK.
Gardasil is well on its way to becoming a major blockbuster for Merck. GlaxoSmithKline [GSK
Loading...
()
] is awaiting FDA approval (for females) of a similar vaccine called Cervarix.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes